Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.23
+2.55 (4.00%)
At close: Oct 20, 2026, 4:00 PM EDT
66.20
-0.03 (-0.05%)
After-hours: Oct 20, 2026, 7:41 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $10.42 billion as of October 20, 2026. It is the 2,084th most valuable company in the world and the 741st biggest in the United States. Its market cap has increased by 89.42% in one year.
Market Cap
10.42B
Enterprise Value
9.05B
1-Year Change
89.42%
Global Rank
Country Rank
#741 United States
Category
ChartMarket Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $10.42B, an increase of 655.38%. That is a compound annual growth rate of 37.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 10.43B | 72.74% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 12.59B |
| Bio-Techne | 11.38B |
| BioMarin Pharmaceutical | 10.93B |
| Madrigal Pharmaceuticals | 10.80B |
| Krystal Biotech | 9.63B |
| Kymera Therapeutics | 9.43B |
| ImmunityBio | 9.29B |
| Twist Bioscience | 8.95B |